Anzeige
❌
Mehr »
Donnerstag, 19.11.2026 - Börsentäglich über 12.000 News
Rund 40 Mio. USD Staatsaufträge bis Juni 2029 gebucht: Jetzt zählt die Marge!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15:46AbbVie and Disco ink $2.5bn pact for next-generation cancer bispecifics
12:46Pfizer inks $2.6bn autoimmune deal with China's Starna for CAR-T therapies
11:46Bridging gaps in rare disease drug access requires strategic rethink
11:46Genomics, Vertex extend drug discovery alliance in $220m deal
11:46FDA approves Regeneron's Livsayis for generalised myasthenia gravis
MiEuropean capital markets require efforts to attract biotech listings
MiGSK's $10.6bn Nuvalent bet pays off with second lung cancer drug approval
MiIsomorphic Labs raises $5bn to advance drug pipeline
MiRevolution Medicines' Rasonque gains EC authorisation for pancreatic cancer
DiEli Lilly inks cancer pact worth up to $5.9bn with Stipple Bio
DiPfizer CEO: 'China will be my major competition by 2030'
DiSeawolf Therapeutics and Sanofi agree $1.2bn drug deal
DiUK biotech sector calls on government to support sector's growth on home soil
DiLilly agrees to acquire Calytrix Bio for $1.5bn
MoJ&J outlays up to $3.3bn to buy ophthalmology specialist Ollin Biosciences
MoRevMed CEO on tackling "complex" launch for wonder pancreatic drug
MoFlagship Pioneering expands to UK with £100m AI-native lab
MoSofinnova Partners backs European life sciences sector with €725M raise
MoAstraZeneca secures FDA approval for Imfinzi combo in MIBC
MoFDA rejects Summit's ivonescimab application for lung cancer
MoHLTH 2026: Potential 2028 US presidential contender Mark Kelly warns pharma over profits
FrFDA puts commissioner's priority voucher framework on ice
FrNeurosterix pockets $105m to advance neuropsychiatry pipeline
FrBMS sets unified research and development structure for 2027
FrTakeda begins US distribution of narcolepsy type 1 drug Orzeyful